EXK ENDEAVOUR SILVER CORP IFRS Annual reports only
Gold and Silver Ores · NYSE · SEC CIK 1277866 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2025*2025-12-31 | FY2024*2024-12-31 | FY2023*2023-12-31 | FY2022*2022-12-31 | FY2021*2021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $467.50M | $217.60M | $205.46M | $210.16M | $165.32M |
| Cost of revenue | $384.70M | $175.60M | $168.85M | $158.63M | $128.95M |
| Gross profit | $82.80M | $42.00M | $36.61M | $51.52M | $36.37M |
| SG&A expense | $23.30M | $14.10M | $12.36M | $10.61M | $10.06M |
| Operating income | $35.70M | $8.30M | $8.70M | $23.46M | $22.23M |
| Interest expense | $14.50M | $1.50M | $1.40M | $1.30M | $985,000 |
| Pretax income | -$104.90M | -$22.00M | $18.25M | $24.95M | $29.69M |
| Income tax | $14.20M | $9.50M | $12.13M | $18.75M | $15.73M |
| Net income | -$119.10M | -$31.50M | $6.12M | $6.20M | $13.96M |
| EBITDA | $108.70M | $38.20M | $36.59M | $48.64M | $46.21M |
| EPS (basic) | -0.42 | -0.13 | 0.03 | 0.03 | 0.08 |
| EPS (diluted) | -0.42 | -0.13 | 0.03 | 0.03 | 0.08 |
| Weighted avg. shares (diluted) | 283.08M | 242.18M | 197.76M | 185.35M | 170.66M |
| Balance sheet | |||||
| Cash & equivalents | $215.40M | $106.40M | $35.29M | $83.39M | $103.30M |
| Short-term investments | $1.00M | $1.10M | $5.13M | $8.65M | $11.20M |
| Receivables | $26.00M | $5.20M | $22.28M | $14.14M | $14.46M |
| Inventory | $62.30M | $36.00M | $27.26M | $19.18M | $27.48M |
| Current assets | $423.20M | $157.60M | $100.77M | $146.33M | $161.76M |
| PP&E, netmay include right-of-use assets (IFRS) | $785.90M | $506.20M | $314.66M | $233.89M | $122.20M |
| Intangibles | — | — | — | $0 | $40,000 |
| Total assets | $1.24B | $719.20M | $474.81M | $399.44M | $294.02M |
| Current liabilities | $276.80M | $78.90M | $58.24M | $52.75M | $40.55M |
| Short-term debt | $8.80M | $5.20M | $3.86M | $6.04M | $4.13M |
| Long-term debt | $3.90M | $115.00M | $4.66M | $8.47M | $6.37M |
| Total debt | $12.70M | $120.20M | $8.52M | $14.51M | $10.49M |
| Total liabilities | $656.60M | $234.80M | $88.47M | $83.54M | $56.62M |
| Shareholders' equity | $579.10M | $484.40M | $386.30M | $315.89M | $237.41M |
| Net debt | -$202.70M | $13.80M | -$26.77M | -$68.88M | -$92.81M |
| Shares outstanding | — | — | 217.25M | 190.00M | 170.54M |
| Cash flow statement | |||||
| Operating cash flow | $67.40M | $19.10M | $11.77M | $54.99M | $23.46M |
| Capital expenditure | $169.20M | $195.40M | $117.79M | $109.72M | $54.09M |
| Free cash flow | -$101.80M | -$176.30M | -$106.02M | -$54.72M | -$30.63M |
| Investing cash flow | -$237.40M | -$183.50M | -$107.19M | -$111.45M | -$38.01M |
| Financing cash flow | $287.00M | $236.00M | $48.12M | $36.76M | $56.65M |
| Depreciation & amortization | $73.00M | $29.90M | $27.89M | $25.18M | $23.98M |
| Stock-based compensation | $3.90M | $3.20M | $3.62M | $3.88M | $3.64M |
Free plan shows the latest 5 periods; Pro shows all 10 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.